Publication | Open Access
Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells
38
Citations
31
References
2012
Year
The combination of lower doses of paclitaxel and CYC3 merits further investigation with the potential for an improved therapeutic index in vivo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1